PROTECTION AGAINST D-AMPHETAMINE TOXICITY

被引:13
作者
DERLET, RW
ALBERTSON, TE
RICE, P
机构
[1] Division of Emergency Medicine and Clinical Toxicology, University of California, Davis, School of Medicine
关键词
Amphetamine; diazepam; haloperidol; propranolol; yohimbine;
D O I
10.1016/0735-6757(90)90194-5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The efficacy of diazepam, haloperidol, propranolol, and yohimbine in antagonizing the toxic manifestations of d-amphetamine were studied in rats. In the control group of animals given 75 mg/kg intraperitoneal (ip) d-amphetamine, 95% developed seizures, and 100% died in mean times of 12.6 ± 1.0 and 50.1 ± 5.9 minutes, respectively. Significant protection against d-amphetamine-induced death was afforded by pretreatment with haloperidol (1.0 to 20.0 mg/kg) or propranolol (20.0 to 30.0 mg/kg). Diazepam (5.0 to 10.0 mg/kg) significantly reduced the incidence of clinically overt seizures but offered no protection against death. Yohimbine (2.5 to 10.0 mg/kg) was ineffective in preventing either seizures or death. When haloperidol (1.0 mg/kg) was administered in combination with diazepam (2.0 mg/kg), the incidence of death was no different than if haloperidol were given alone. In combination, haloperidol (1.0 mg/kg) and propranolol (10.0 mg/kg) reduced death more than either agent alone. These data support a protective role of haloperidol or propranolol in the treatment of d-amphetamine intoxication and show no protection with diazepam or yoshimbine. © 1990.
引用
收藏
页码:105 / 108
页数:4
相关论文
共 29 条
[1]  
Derlet, Rice, Horowitz, Et al., Amphetamine toxicity: Experience with 127 cases, J Emerg Med, 7, pp. 157-161, (1989)
[2]  
Bailey, Amphetamine detection during toxicology screening of a university medical center patient population, Clin Toxicol, 25, pp. 399-409, (1987)
[3]  
Gawin, Ellinwood, Cocaine and other stimulants, N Engl J Med, 318, pp. 1173-1182, (1988)
[4]  
Zalis, Parmiley, Fatal amphetamine poisoning, Arch Intern Med, 112, pp. 822-826, (1963)
[5]  
McGuigan, Toxicology of drug abuse, Emerg Med Clin North Am, 2, pp. 94-97, (1984)
[6]  
Jaffe, Drug addiction and drug abuse, The Pharmacological Basis of Therapeutics, pp. 550-551, (1985)
[7]  
Brown, Osterloh, Multiple severe complications from recreational ingestion of MDMA (‘ecstasy’), JAMA, 258, pp. 780-781, (1987)
[8]  
Buchanan, Brown, ‘Designer drugs’ a problem in clinical toxicology, Med Toxicol, 3, pp. 1-17, (1988)
[9]  
Bryson, Comprehensive Review in Toxicology, pp. 369-372, (1989)
[10]  
Davis, Logston, Hickenbottom, Antagonism of acute amphetamine intoxication by haloperidol and propranolol, Toxicol Appl Pharmacol, 29, pp. 397-403, (1974)